MedTrace Logo

Study on Biomarkers for Early Diagnosis of Alzheimer's Disease

NCT04575337 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2026-03-23

No results posted yet for this study

Summary

The project of Bio-AD is a population- based cohort study among the elderly in China.

The project includes not only Alzheimer's disease (AD including familial AD and sporadic AD), but also other clinical stage of AD, as well as elderly people with normal cognitive function.

The project will collect, detect and screen the special biomarkers at different clinical stage of AD based on body fluid, gene and brain image. The standard and consistent assessment protocols are employed to obtain clinical, cognitive, genetic, neuroimaging and biospecimen data.

The purpose of this project is to establish a panel of biomarkers which could be used to diagnose AD at the early stage, and to establish a risk prediction models for AD to predict the 5-years risk of the onset and progression of AD among elderly population in China.

Conditions

  • Alzheimer Disease

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Jianping Jia, Doctor · Xuanwu Hospital of Capital Medical University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-28
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04575337 on ClinicalTrials.gov